Tradestie Institutional Equity Comparison Engine

MXCT vs CTKB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CTKB Overall Edge

CTKB Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cytek Biosciences, Inc. Common Stock (CTKB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus CTKB at N/M Forward P/E and -22.5% operating margin (+1.8% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CTKB sits in CONSOLIDATION (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MXCT N/M vs CTKB N/M Fwd P/E
Growth & Margin Winner CTKB
Op Margin -85.5% vs -22.5% ยท YoY +48.7% vs +1.8%
Momentum & Technical Winner CTKB
1Y -19.4% vs +16.4% ยท 52W Pos 63% vs 91%
Options & Structure Winner CTKB
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (<1st %ile IV)
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0
CTKB NASDAQ
Cytek Biosciences, Inc. Common Stock
Laboratory Analytical Instruments
$6.12
-3.16% 1D
Market Cap $826.6M
1M Return +12.71%
1Y Return +16.35%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 60.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MXCT -19.41% CTKB +16.35% Spread: +35.76 pp (CTKB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MXCT Revenue CTKB Revenue MXCT Op. Margin CTKB Op. Margin Margin Edge
FY2019 $10M N/A -93.7% N/A MXCT
FY2020 $20M $90M -71.6% 14.7% CTKB
FY2021 $20M $130M -84.3% 7.2% CTKB
FY2022 $30M $160M -95.2% -1.1% CTKB
FY2023 $20M $190M -247.7% -14.4% CTKB
FY2024 $20M $200M -230.5% -10.2% CTKB
FY2025 $20M $200M -247.6% -20.0% CTKB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MXCT (2) vs CTKB (6)
Institutional Metric MXCT CTKB Criterion Row Winner
Market Capitalization Scale $132.2M $826.6M Larger Scale CTKB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +48.7% +1.8% Higher Growth MXCT
Operating Margin (TTM) Profitability -85.5% -22.5% Higher Margin CTKB
Net Profit Margin Profitability -81.4% -39.1% Higher Margin CTKB
Return on Equity (ROE) Capital Efficiency -16.9% -23.2% Higher ROE MXCT
52-Week Range Position Momentum 63% ($1โ€“$2) 91% ($3โ€“$6) Stronger Trend CTKB
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 96% Vol 0.71ฮฒ ยท 67% Vol Lower Realized Risk CTKB
Unified Institutional Score Composite Signal 41.7 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite CTKB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MXCT vs CTKB Buy Guide
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CTKB CONSOLIDATION
16d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CTKB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MXCT nor CTKB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.